dr. burgess for a moment, only the federal government could do it this. this is something the private sector the afford having said that, and great advantage to figure out how to set this up in a way that avoided bureaucracy induced problems, and the public/private partnership is probably in order. there are ways to partner the costs. users of the data could be charged to use the data and they could pay for that data with dollars or in contributions of their own data into the system. in terms of it is already being done, those are microcosmic by comparison, not at systematic testing, i remember 23, an mri, no one is testing those and so forth and fluids and as i said, this is a mother ship in which other concepts can dock and trade data and that is why after being funded, managed in some regard by the federal government. >> i was originally going to comment on dr. hanlon's comments but there's a lot of rich discussion. one additional would make that has already been said more broadly is whether it is a big longitudinal study or a smaller study taking adva

dr. burgess. >> i thank the gentle lady for yielding. thank our witnesses for being here. dr. laky, good to see you. >> this will be one of the most serious public health crises of the last hundred years. at our last hearing we had a great deal to discuss. many of the brave pronouncements from september were found to be nonoperational by the middle of october oh. there were failures in dealing with the crisis. certainly communication was lacking. systems and protocols broke down. provisions that we all thought were readily at hand were never in place to begin with. i hope we know better than to let it happen again. this summer's emergency, to me, emphasized one thing. have a lot of hue mill ti when dealing with the virus. it is difficult to predict. as a physician, one of my big concerns, since july has been the safety and protection of health care workers. i want to thank the cdc for being responsive to my telephone calls and the various conference calls we had over the summer were helpful. i've got to tell you. until you have this thing in your backyard it's hard to estimate

dr. burgess recognized for five minutes. >> thank you. i want to thank all our witnesses being here today and bearing with what has been a long but very informative hearing. dr. gold, there is a difference between the patient you get at your center. there is not direct access i have ebola and will go to dr. bold's center in omaha, all the patients that came in that thursday night and had to be and the doctor's case had to be winnowed out of the other mode in the emergency room. in your situation, a patient only comes after they've been identified, is that correct? >> thus far the patients we have had midst to the biocontainment unit have come with a dc rrr diagnosis of ebola. given our national reputation, the number of phone calls, e-mails, even emergency visits has actually been quite interesting with people with febrile illnesses saying, please tell me if i have ebola. >> so then patients that arrive in your emergency room, you outline you have a dedicated laboratory handling of the specimens from an ebola patient but that's someone you

dr. cheryl burgess joining us with that. i can't wait to hear. this sounds too good to be true. >> yes, there are two things fda cleared. and you'll be the first to know. >> i'm excited. i understand that one of them that cellulite, the other tackles excess fat. >> yes. let's start tw the cellulite one. a lot of women suffer from that. ironically, me y fat is positioned a little bit different. >> a dimply and you can be a s' zero and still haveocellulite. so it's a device used in the doctor's office. it tends to break the bands up harboring an the fat right under the skin that causes the dimpling. so you can see the effects in about three days. and it lasts for more than a year. .ver 90% satisfaction i so this is for one year. does it take that long? >> no, you can see a difference within a week. >> oh. >> yeah. but it persists, and they follow patients out to about a year, and thought that they still had s you see in the after. how treatments do you have to have? >> usually one treatment. >> and how expensive is it? >> we don't know yet because

dr. sheryl burgess joins us with hair growth advancement and a look at how to make the pores smaller.me. >> thank you. >> you just came back from a big meeting. >> san diego. yes. i've been traveling a lot. but i have great information, some new innovative advances in the field of dermatology. >> fantastic. let's begin with hair growth. a lot of men and women too are interested in that. is this something new in that field? >> it's not really new. but it's getting a lot of attention now. it's something that we've been doing for many, many years. but you've heard of stem cells or prp, which is platelet rich plasma, and it's a technique. i know it was in the news about kim kardashian getting a vampire facial. they're drawing your blood and using the platelet rich plasma and putting it on the skin and inoculating it back to the skin. and it has a lot of stem cells or growth factor. stem cell factor. va vascular growth pack for. >> you get a lot shot blood into your head. >> yes. it seems unusual. these are only one treatment. so we see a lot of stimulation from hair growth. >> dramatic. >

dr. burgess? >> i was going to thank the panel, too. i have been through a number of these hearings. our committee, of course, has done hearings. i was allowed to sit in homeland security and they did a field hearing in dallas. i sat through the hearing on foreign affairs last september. this has been the most informative panel that i have had the pleasure to hear from. i really appreciate it. i know it was a long day and i know we made you wait a long time. but i really appreciate you guys sticking with us and sharing with us the information that you shared, because it's been absolutely critical. i'll yield back. >> through, doctor. i want to add to that. i almost had the feel that the first panel we had today was speaking the ball. we got this, and we can be confident and i don't agree. after we had our hearing several weeks ago, put forth recommendations, we needed some level of travel restrictions, people ought to be isolated for 21 days. what i hear, not only did you do that along with the hospitals of so many colleagues, but your employees didn't complain. they recognize they d

dr. burgess. >> i thank the gentle lady for yielding. thank our witnesses for being here. dr. laky, good to see you. >> this will be one of the most serious public health crises of the last hundred years. at our last hearing we had a great deal to discuss. many of the brave pronouncements from september were found to be nonoperational by the middle of october oh. there were failures in dealing with the crisis. certainly communication was lacking. systems and protocols broke down. provisions that we all thought were readily at hand were never in place to begin with. i hope we know better than to let it happen again. this summer's emergency, to me, emphasized one thing. have a lot of hue mill ti when dealing with the virus. it is difficult to predict. as a physician, one of my big concerns, since july has been the safety and protection of health care workers. i want to thank the cdc for being responsive to my telephone calls and the various conference calls we had over the summer were helpful. i've got to tell you. until you have this thing in your backyard it's hard to estimate

dr. burgess? >> i was going to thank the panel, too. i have been through a number of these hearings. our committee, of course, has done hearings. i was allowed to sit in homeland security and they did a field hearing in dallas. i sat through the hearing on foreign affairs last september. this has been the most informative panel that i have had the pleasure to hear from. i really appreciate it. i know it was a long day and i know we made you wait a long time. but i really appreciate you guys sticking with us and sharing with us the information that you shared, because it's been absolutely critical. i'll yield back. >> through, doctor. i want to add to that. i almost had the feel that the first panel we had today was speaking the ball. we got this, and we can be confident and i don't agree. after we had our hearing several weeks ago, put forth recommendations, we needed some level of travel restrictions, people ought to be isolated for 21 days. what i hear, not only did you do that along with the hospitals of so many colleagues, but your employees didn't complain. they recognize they d

dr. michael burgess from dallas, texas. his medical expertise has been of significant value, as we consider public policy questions regarding health care and it is great to have you, if you would make a few comments. >> thank you. i thank you for the invitation to come up from pennsylvania. i've add number of opportunities to talk to people. both in the dallas area where i'm from as well as down in the houston area, texas medical center. last monday, i was at the invitation of manhattan institute at boston. so this is -- this exercise has attracted a lot of attention around the country. and i think that's appropriate. for me it is great to be at the roundtables. we are hearing from people on the front lines if the development and to know what we can do to make things happen faster. because that is, after all, what the name of the blame is. thank you mr. chairman. i yield back. >> thank you, michael. next i would like to have each of our distinguished guests to take two minutes to introduce themselves. tell us who you are. a